ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $347,376 | -20.7% | 12,928 | +6.1% | 0.00% | 0.0% |
| Q2 2023 | $438,209 | -0.4% | 12,186 | -0.4% | 0.00% | 0.0% |
| Q1 2023 | $439,791 | -12.8% | 12,230 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $504,445 | +21.0% | 12,437 | -0.8% | 0.00% | 0.0% |
| Q3 2022 | $417,000 | -3.5% | 12,540 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $432,000 | -89.0% | 12,503 | -85.3% | 0.00% | -80.0% |
| Q1 2022 | $3,918,000 | -64.7% | 85,199 | -49.1% | 0.01% | -64.3% |
| Q4 2021 | $11,104,000 | -18.9% | 167,225 | -23.8% | 0.01% | -26.3% |
| Q3 2021 | $13,694,000 | +154.3% | 219,313 | +237.2% | 0.02% | +171.4% |
| Q2 2021 | $5,386,000 | +17.6% | 65,031 | -5.9% | 0.01% | 0.0% |
| Q1 2021 | $4,581,000 | +193.7% | 69,086 | +239.5% | 0.01% | +133.3% |
| Q4 2020 | $1,560,000 | +79.9% | 20,347 | +1.0% | 0.00% | +50.0% |
| Q3 2020 | $867,000 | -89.3% | 20,145 | -89.3% | 0.00% | -86.7% |
| Q2 2020 | $8,108,000 | +20.5% | 187,721 | -19.7% | 0.02% | 0.0% |
| Q1 2020 | $6,726,000 | -34.3% | 233,755 | +44.9% | 0.02% | 0.0% |
| Q4 2019 | $10,233,000 | +126.5% | 161,330 | +0.7% | 0.02% | +114.3% |
| Q3 2019 | $4,517,000 | +1.9% | 160,272 | -4.2% | 0.01% | 0.0% |
| Q2 2019 | $4,434,000 | +619.8% | 167,317 | +398.6% | 0.01% | +600.0% |
| Q1 2019 | $616,000 | – | 33,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |